Prepare for the PANCE Board Exam with our comprehensive quiz. Study with detailed questions and explanations. Sharpen your skills and boost your confidence for exam day!

Multiple Choice

Which of the following is a contraindication to methotrexate usage in ectopic pregnancy?

Methotrexate for ectopic pregnancy is reserved for patients who are hemodynamically stable and meet certain criteria, because it relies on medical management and close follow-up rather than immediate surgical control. The key is that MTX is not safe when there is active bleeding risk or rupture; in that situation, the patient needs urgent surgical intervention. Being hemodynamically unstable indicates a ruptured or rapidly rupturing ectopic pregnancy with ongoing bleeding. In this setting, waiting for MTX to work could be catastrophic, so surgery is necessary right away. That’s why instability is the absolute contraindication to using methotrexate. The other factors—embryo size being larger than about 3.5 cm, a higher BHCG level, or the patient not willing to adhere to serial BHCG monitoring—are relative or practical considerations that can influence the likelihood of MTX success, but they don’t mandate immediate surgical management the way instability does. If a patient can comply with follow-up and meets stability criteria, MTX may still be considered, whereas inability to ensure follow-up makes medical management inappropriate.

Methotrexate for ectopic pregnancy is reserved for patients who are hemodynamically stable and meet certain criteria, because it relies on medical management and close follow-up rather than immediate surgical control. The key is that MTX is not safe when there is active bleeding risk or rupture; in that situation, the patient needs urgent surgical intervention.

Being hemodynamically unstable indicates a ruptured or rapidly rupturing ectopic pregnancy with ongoing bleeding. In this setting, waiting for MTX to work could be catastrophic, so surgery is necessary right away. That’s why instability is the absolute contraindication to using methotrexate.

The other factors—embryo size being larger than about 3.5 cm, a higher BHCG level, or the patient not willing to adhere to serial BHCG monitoring—are relative or practical considerations that can influence the likelihood of MTX success, but they don’t mandate immediate surgical management the way instability does. If a patient can comply with follow-up and meets stability criteria, MTX may still be considered, whereas inability to ensure follow-up makes medical management inappropriate.